/

Empresas

Bl

No verificado

Blue Earth Diagnostics

Sobre qué escribimos

BiotecnologíaEventosIndustriaOncologíaSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa

04/11/2024

Industria

Oncología

Salud

Medicina nuclear

Farmacéutica

Biotecnología

Blue Earth Diagnostics, a Bracco Company, Applauds New CMS Rule to Support Patient Access Through Improved Payment for Specialized Diagnostic Radiopharmaceuticals

Fuente

Blue Earth Diagnostics

Editor

1.00

0

01/10/2024

Multimedia

Eventos

Ferias y Congresos

Industria

Oncología

Salud

Medicina nuclear

Medicina - Varios

Farmacéutica

Biotecnología

Results of POSLUMA® (Flotufolastat F 18) Performance in Recurrent Prostate Cancer After Radical Prostatectomy at Low Prostate Specific Antigen (PSA) Levels Presented at ASTRO

Fuente

Blue Earth Diagnostics

Editor

1.00

0

24/09/2024

Eventos

Industria

Biotecnología

Salud

Medicina nuclear

Farmacéutica

Oncología

Blue Earth Diagnostics Highlights Presentations on POSLUMA® (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting

Fuente

Blue Earth Diagnostics

Editor

1.00

0

30/07/2024

Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating Diagnostic Performance of POSLUMA® (Flotufolastat F 18) and Clinical Trial Enrollment in African American Men with Prostate Cancer

Fuente

Blue Earth Diagnostics

Editor

1.00

0

Seguidores

0

Compatibilidad

0